Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 102
Abstract
Leukodystrophies are devastating diseases characterized by dys- and hypo-myelination. While there are a number of histological and imaging studies of these disorders, there are limited biochemical data available. We undertook targeted lipidomic analyses of Pelizaeus-Merzbacher disease (PMD) fibroblasts, PMD lymphocytes, and 158JP oligodendrocytes, a murine model of PMD, to define the lipid changes in these cell models. Further targeted metabolomics analyses were conducted to obtain a preliminary evaluation of the metabolic consequences of lipid changes and gene mutations in these cell models. In both PMD fibroblasts and lymphocytes, and 158JP oligodendrocytes, ethanolamine plasmalogens were significantly decreased. Labeling studies with 158JP oligodendrocytes further demonstrated a decreased rate of lipid remodeling at sn-2. Targeted metabolomics analyses of these cells revealed dramatic increases in cellular levels of myo-inositol. Further uptake studies demonstrated increased rates of myo-inositol uptake by PMD lymphocytes. Our data demonstrating PlsEtn decrements, support previous studies indicating leukodystrophy cells possess significant peroxisomal deficits. Our data for the first time also demonstrate that decrements in peroxisomal function coupled with the PLP1 gene defects of PMD, result in changes in the function of membrane myo-inositol solute carriers resulting in dramatic increases in cellular myo-inositol levels.Keywords
This publication has 30 references indexed in Scilit:
- The burden of inherited leukodystrophies in childrenNeurology, 2010
- Functions and biosynthesis of plasmalogens in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2004
- Proton MRS profile of cerebral metabolic abnormalities in Krabbe diseaseNeurology, 2003
- Cerebral proton magnetic resonance spectroscopy in infantile Alexander diseaseJournal of Neurology, 2003
- Deficiency in ethanolamine plasmalogen leads to altered cholesterol transportJournal of Lipid Research, 2003
- Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomesJournal of Cell Biology, 2002
- Quantitative Proton Magnetic Resonance Spectroscopy of Childhood AdrenoleukodystrophyNeuropediatrics, 1998
- Plasmalogen Phospholipids Are Involved in HDL-Mediated Cholesterol Efflux: Insights from Investigations with Plasmalogen-Deficient CellsBiochemical and Biophysical Research Communications, 1998
- Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivoJournal of Neurology, 1993
- The Polyol PathwayDrugs, 1986